Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C017821 |
2-amino-3-methyl-9H-pyrido(2,3-b)indole |
SULT1A2 protein results in increased activity of 2-amino-3-methyl-9H-pyrido(2,3-b)indole | increases activity | 14729582
|
C117220 |
3-nitrobenzanthrone |
SULT1A2 protein results in increased activity of 3-nitrobenzanthrone | increases activity | 15805261
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of SULT1A2 mRNA | affects expression | 18246545
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of SULT1A2 mRNA | increases expression | 18246545
|
D015081 |
2-Naphthylamine |
SULT1A2 protein results in increased sulfation of 2-Naphthylamine | increases sulfation | 17433394
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SULT1A2 mRNA | increases expression | 19150397
|
C040048 |
caffeic acid |
SULT1A2 protein results in increased sulfation of caffeic acid | increases sulfation | 17433394
|
C034221 |
catechol |
SULT1A2 protein results in increased sulfation of catechol | increases sulfation | 17433394
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SULT1A2 mRNA | decreases expression | 20106945
|
D003907 |
Dexamethasone |
Dexamethasone affects the expression of SULT1A2 mRNA | affects expression | 15102944
|
D002945 |
Cisplatin |
SULT1A2 protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
C099406 |
L 742694 |
L 742694 affects the expression of SULT1A2 mRNA | affects expression | 15102944
|
C014593 |
N-hydroxy-4-aminobiphenyl |
SULT1A2 protein results in increased sulfation of N-hydroxy-4-aminobiphenyl | increases sulfation | 17433394
|
C025299 |
polyphenols |
polyphenols results in decreased expression of SULT1A2 mRNA | decreases expression | 16293270
|
C059514 |
resveratrol |
SULT1A2 protein results in increased sulfation of resveratrol | increases sulfation | 16418064
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of SULT1A2 mRNA | increases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.90 | 14514962 15322242 11752688 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
8.98 | 17670903 12690470 15814532 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
8.98 | 16538975 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
2.76 | 11798837 17638652 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.33 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.43 | 16835633 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.57 | 16183991 16162502 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.91 | 10982225 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
7.74 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.74 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.29 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.07 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.95 | 14601052 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.33 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
1.97 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
1.97 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.69 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
4.69 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
4.69 | 16227395 19321006 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.64 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
3.04 | 12023789 16685392 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
5.03 | 6189445 18337622 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
5.03 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.49 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.60 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.62 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.62 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.94 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 12621046 8697196 15668235 15340226 16354765 |
MESH:D003092 |
Colitis |
|
resveratrol |
4.17 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
6.02 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
6.02 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
6.02 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
2.81 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.81 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.77 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
2.62 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.62 | 10048152 15322242 20055451 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.45 | 12438553 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.79 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
3.99 | 16286809 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.73 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.26 | 10915739 16485898 18071297 12392966 19416960 16177239 12705907 12594235 11287661 12540782 16781746 14986274 19739265 11834606 16081117 19370779 14550746 12153990 11743745 2444490 16109766 15619225 17522070 10774834 10663392 12958197 18713872 19923254 17906064 19085960 14725611 19420014 15968718 16227642 11421492 19164858 11461765 17562736 11739529 16393943 11529661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
6.26 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.26 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.16 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
8.25 | 12231392 15033597 12649298 19839026 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.25 | 11462148 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.50 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
11.73 | 19703484 |
MESH:D004487 |
Edema |
|
resveratrol |
11.73 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.73 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
4.06 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 9294722 10568697 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.89 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.65 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
4.65 | 15464296 16481741 15173087 16785472 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
2.88 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.62 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.62 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.74 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
3.73 | 15102660 15464296 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.32 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.44 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.34 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.93 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
3.08 | 7520565 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.23 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.62 | 16170182 16200630 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 18606429 8697196 15340226 16959395 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.72 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.03 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.06 | 16873680 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.65 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
8.65 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.65 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.33 | 17488730 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.69 | 17600658 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
12.15 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
polyphenols |
12.15 | 16366677 |
MESH:D007249 |
Inflammation |
|
resveratrol |
12.15 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
12.15 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.61 | 16624496 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
5.20 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
10.16 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
10.16 | 12231392 15190930 12649298 18289764 19839026 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.16 | 10903974 8314463 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.76 | 12371664 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.86 | 11231351 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.59 | 16087638 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
2.48 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.48 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.18 | 11587558 16611625 19460945 12969438 12587719 19784758 16610002 19014921 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
4.18 | 16698588 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.26 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
4.61 | 19073162 20405173 19321006 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.61 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.12 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
3.53 | 17225452 6189445 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
3.53 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.53 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.33 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.89 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.30 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
3.13 | 11606380 8985016 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
3.67 | 16248763 12393984 12883367 18505091 12374674 17761969 11135225 16809738 18332650 15577323 18176117 17023156 16432458 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.67 | 17992120 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.82 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.61 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.25 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.41 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
7.63 | 15744524 16118317 15867202 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
7.63 | 16267019 17935668 17164350 14749477 17049120 16490592 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.92 | 17962980 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
3.56 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
3.04 | 16456233 17188708 16317513 16525036 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
9.08 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.08 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.81 | 17322642 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
2.95 | 16773208 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
4.04 | 8985016 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.55 | 15464296 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.25 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.46 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.43 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
8.43 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.75 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.43 | 17929310 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.29 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
2.88 | 19769630 15464296 6897625 17225452 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.41 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
3.00 | 19003803 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.34 | 15464296 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.41 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.25 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.56 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
9.76 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.76 | 11896295 11118676 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
3.63 | 17636462 17675339 17804756 17718901 15767336 16731767 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
4.45 | 15464296 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.65 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.28 | 16314181 15827377 16317513 17520802 17058453 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
4.05 | 18379247 11700416 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
4.46 | 14601052 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
5.76 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.76 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.41 | 15464296 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.37 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
2.33 | 15958060 17522103 18396642 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
3.51 | 15138204 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.51 | 16321402 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
5.31 | 17997062 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.66 | 17225452 15464296 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.24 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Naphthylamine |
5.82 | 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
5.82 | 17225452 12973940 15464296 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.01 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
9.82 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
9.82 | 17473185 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
4.17 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
11.98 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
11.98 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.65 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.34 | 17488730 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.78 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |